OSR Holdings, Inc.
OSRH
$0.60
-$0.04-6.55%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/20/2025
-
Newsfile Corp. - News Releases
10/16/2025
-
TipRanks Financial Blog
10/14/2025
-
SeekingAlpha.com: All News
10/14/2025
-
Seeking Alpha - Healthcare
10/14/2025
-
GuruFocus
10/14/2025
-
TipRanks Financial Blog
10/14/2025
-
The Fly
10/14/2025
-
PR Newswire
10/3/2025
-
Ticker Report
9/9/2025
-
GuruFocus
9/9/2025
-
SeekingAlpha.com: All News
9/9/2025
-
Seeking Alpha - Healthcare
9/9/2025
-
TipRanks Financial Blog
9/9/2025
-
The Fly
9/9/2025
-
PR Newswire
9/9/2025
-
TipRanks Financial Blog
8/20/2025
-
Simply Wall St
8/1/2025
-
GuruFocus
8/1/2025
-
GuruFocus
8/1/2025
-
PR Newswire
7/31/2025
-
GuruFocus
7/31/2025
-
GuruFocus
7/31/2025
-
PR Newswire
7/30/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Apr 20 and 24 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
425 635 7700
Address
10900 NE 4th Street
Bellevue, WA 98004
Bellevue, WA 98004
Country
Year Founded
--
Business Description
Sector
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy...
more